'Copies' of Ozempic are sold for $14: India launches generics of semaglutide after patent expiration
India has introduced generic versions of semaglutide, the active ingredient in Ozempic, at a lower price following the expiration of its patent.
The patent for Ozempic expired, revealing an interesting fact about the price of its copy in Argentina
The expiration of the Ozempic patent will lead to a significant decrease in prices as generic versions from Indian pharmaceutical companies enter the market, but Argentine copies remain notably expensive.
Medications: "Our Supplies of Active Ingredients Are Still Sufficient"
Josip Meštrović, the Germany head of generics manufacturer Zentiva, expresses concerns about the potential impact of geopolitical tensions on Germany's pharmaceutical supply chain due to blocked shipping routes in the Hormuz Strait.
The Patents for Weight Loss Drugs Expire: Generics Are Coming
The expiration of patents for weight loss drugs is paving the way for the introduction of generic alternatives in the global obesity medication market.